Physician profile
Umer Muhammad
NPI 1629698865
$393.38
in general payments reported to CMS, 2019-2025
11 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $227 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $103.09 | 2024 | |
| Merck Sharp & Dohme LLC | $65.94 | 2024-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Abbott Laboratories | $49.26 | 2025 | Freestyle Libre |
| Dynavax Technologies Corporation | $39.64 | 2024 | Heplisav-B |
| Glaxosmithkline, LLC. | $35.86 | 2025 | Bexsero, Rotarix |
| Genzyme Corporation | $19.16 | 2024 | |
| Exact Sciences Corporation | $17.48 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $16.08 | 2025 | Wegovy |
| Ironwood Pharmaceuticals, INC | $16.06 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $15.67 | 2024 | Rexulti |
| Lundbeck LLC | $15.14 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umer Muhammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.